Alkermes to Take Part in the BofA Securities 2021 Virtual Healthcare Conference

Rhea-AI Summary

Alkermes plc (Nasdaq: ALKS) will participate in a virtual fireside chat at the BofA Securities 2021 Healthcare Conference on May 12, 2021, at 2:45 p.m. ET. The presentation can be accessed through the Investors tab on their website and will be archived for 14 days. Alkermes is a biopharmaceutical company focused on developing medicines for neurological and oncological diseases, with a portfolio targeting addiction and schizophrenia. The company operates from Dublin, Ireland, and has facilities in Massachusetts, Ireland, and Ohio.

Positive

• Participation in a reputable healthcare conference may enhance visibility and investor engagement.
• Focus on neuroscience and oncology aligns with current market trends in biopharmaceuticals.

Negative

• None.

DUBLIN, May 5, 2021 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a virtual fireside chat at the BofA Securities 2021 Healthcare Conference on Wednesday, May 12, 2021 at 2:45 p.m. ET (7:45 p.m. BST). The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

About Alkermes plc

Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction and schizophrenia, and a pipeline of product candidates in development for schizophrenia, bipolar I disorder, neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Contact:
Alex Braun
Investor Relations
+1 781 296 8493

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/alkermes-to-take-part-in-the-bofa-securities-2021-virtual-healthcare-conference-301284887.html

SOURCE Alkermes plc

FAQ

When is Alkermes participating in the BofA Securities Healthcare Conference?

Alkermes will participate on May 12, 2021, at 2:45 p.m. ET.

How can I access Alkermes' presentation at the conference?

The presentation can be accessed through the Investors tab on Alkermes' website.

Will the Alkermes conference presentation be available later?

Yes, it will be archived for 14 days after the event.

What is the main focus of Alkermes as a biopharmaceutical company?

Alkermes specializes in developing innovative medicines for neuroscience and oncology, particularly targeting addiction and schizophrenia.

What stock symbol does Alkermes trade under?

Alkermes trades under the symbol ALKS.